CHIH


MSCI China Health Care ETF

Reasons to Consider CHIH

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Key Information As of 05/26/22

Inception Date 12/07/18
Total Expense Ratio 0.65%
Net Assets $10.81 million
NAV $14.23
Fact Sheet

ETF Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

ETF Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Trading Details As of 05/26/22

Ticker CHIH
Bloomberg Index Ticker NU722071
CUSIP 37954Y541
ISIN US37954Y5419
Primary Exchange NYSE Arca
Shares Outstanding 760,002
Number of Holdings 85
30-Day Median Bid-Ask Spread 1.82%

Distributions As of 05/26/22

30-Day SEC Yield 0.45%
Distribution Frequency Semi-Annually

ETF Prices As of 05/26/22

NAV $14.23 Daily Change -$0.22 -1.53%
Market Price $14.44 Daily Change -$0.03 -0.20%

Performance History

As of recent
(03/31/22)
As of recent
(03/31/22)
Fund NAV Market Price Index
1 Year -36.34% -37.24% -35.97%
3 Years 1.48% 0.78% 2.23%
Since Inception 5.07% 4.74% 5.83%
1 Year -48.82% -49.67% -48.53%
3 Years -2.91% -3.82% -2.19%
Since Inception 1.40% 0.74% 2.13%
Year-to-Date -19.30% -19.98% -19.20%
1 Month -6.41% -7.52% -6.39%
3 Months -19.30% -19.98% -19.20%
Since Inception 17.82% 16.61% 20.65%
Year-to-Date -28.19% -29.63% -28.06%
1 Month -11.02% -12.05% -10.97%
3 Months -16.54% -18.84% -16.43%
Since Inception 4.84% 2.55% 7.41%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 05/26/22

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
9.70 2269 HK WUXI BIOLOGICS CAYMAN INC BL6B9P1 6.45 162,580 1,049,050.21
8.00 1093 HK CSPC PHARMACEUTI 6191997 0.95 912,808 865,171.25
5.57 BGNE BEIGENE LTD-ADR BYYWPW6 131.26 4,588 602,220.88
5.31 1177 HK SINO BIOPHARMACEUTICAL B00XSF9 0.53 1,083,100 573,999.61
3.64 2359 HK WUXI APPTEC CO LTD-H BGHH0L6 11.10 35,456 393,421.06
3.50 1099 HK SINOPHARM GROUP CO-H B3ZVDV0 2.45 154,800 378,635.99
3.03 1548 HK GENSCRIPT BIOTECH CORP BD9Q2J2 2.57 127,800 328,061.76
2.93 1801 HK INNOVENT BIOLOGICS INC BGR6KX5 2.78 113,900 317,047.89
2.85 300760 C2 SHENZHEN MINDR-A BHQK864 41.85 7,361 308,056.24
2.69 1066 HK SHANDONG WEIG-H 6742340 1.04 279,300 290,342.63
2.21 2196 HK FOSUN PHARMA-H B8XBQ96 4.00 59,600 238,410.63
2.19 ZLAB ZAI LAB LTD-ADR BD9GVY0 30.00 7,889 236,670.00
2.15 867 HK CHINA MEDICAL SY B6WY993 1.37 170,100 232,299.78
2.07 3692 HK HANSOH PHARMACEU BJYKB72 1.66 134,500 223,776.86
2.04 603259 C1 WUXI APPTEC CO LTD-A BHWLWV4 13.01 16,924 220,254.88
1.99 600436 C1 ZHANGZHOU PIEN-A BP3R7Z6 43.62 4,926 214,869.64
1.88 300015 C2 AIER EYE HSPTL-A BD5CLQ4 5.07 40,024 202,737.73
1.87 570 HK TRAD CHI MED 6971779 0.50 406,800 202,631.71
1.77 600276 C1 JIANGSU HENGRU-A BP3R369 4.29 44,672 191,636.67
1.61 2607 HK SHANGHAI PHARM-H B4Q4CJ6 1.57 110,900 173,774.63
1.59 LEGN LEGEND BIOTECH CORP-ADR BMX9K07 39.35 4,375 172,156.25
1.46 6078 HK HYGEIA HEALTHCAR BMX09H0 4.92 32,200 158,340.82
1.29 300122 C2 CHONGQING ZHIF-A BD5CJY8 12.76 10,933 139,540.32
1.24 000538 C2 YUNNAN BAIYAO-A BD5CP95 8.32 16,114 134,064.14
1.21 1530 HK 3SBIO INC BY9D3L9 0.70 188,700 131,254.51
1.21 3759 HK PHARMARON BEIJ-H BK72QD3 10.22 12,750 130,266.95
1.16 853 HK MICROPORT SCIENTIFIC CORP B676TW7 1.72 73,200 125,890.96
1.07 000963 C2 HUADONG MEDICINE CO LTD-A BD5CM94 5.41 21,411 115,824.89
1.01 3347 HK HANGZHOU TIGER-H BMZC7F8 8.89 12,320 109,472.40
0.94 600196 C1 SHANGHAI FOSUN-A BP3R3M5 6.34 16,074 101,889.42
0.89 HCM HUTCHMED CHINA-ADR BYXV9H7 9.06 10,593 95,972.58
0.84 1951 HK JINXIN FERTILITY BJ9JY53 0.67 133,900 90,237.27
0.80 300896 C2 IMEIK TECHNOLO-A BNR4MY3 71.65 1,200 85,974.49
0.79 300142 C2 WALVAX BIOTECHNOLOGY CO-A BD5CG36 7.05 12,100 85,332.49
0.76 600332 C1 GUANGZHOU BAIY-A BP3R4Q6 4.49 18,359 82,391.69
0.69 002001 C2 ZHEJIANG NHU CO LTD-A BD5CH66 3.04 24,408 74,095.30
0.66 6185 HK CANSINO BIOLOGICS INC-H BJKDJS2 9.20 7,700 70,823.54
0.64 603392 C1 BEIJING WANTAI-A BMXTWX4 21.63 3,190 68,984.05
0.58 000661 C2 CHANGCHUN HIGH-A BD5CDB3 22.31 2,828 63,094.17
0.57 300347 C2 HANGZHOU TIGER-A BD5CCK5 11.71 5,216 61,102.28
0.52 002821 C2 ASYMCHEM LABOR-A BD6V5C4 35.08 1,613 56,583.49
0.51 300759 C2 PHARMARON BEIJ-A BK4XYC4 15.68 3,500 54,867.09
0.51 601607 C1 SHANG PHARM -A BP3R4Z5 2.65 20,700 54,766.19
0.48 002422 C2 SICHUAN KELUN-A BD5CL08 2.64 19,700 52,004.08
0.45 002294 C2 SHENZHEN SALUBRIS PHARM-A BD5CM05 3.77 13,000 48,989.21
0.44 603858 C1 SHANDONG BUCHA-A BYW5NC3 2.90 16,287 47,277.04
0.43 688180 C1 SHANGHAI JUNSH-A BLCD7F7 13.13 3,563 46,780.67
0.43 600998 C1 JOINTOWN PHARMACEUTICAL-A BP3R541 1.78 26,070 46,290.53
0.43 300601 C2 SHENZHEN KANGT-A BFY8HT2 8.98 5,143 46,199.59
0.42 002603 C2 SHIJIAZHUANG Y-A BD5CHJ9 3.26 13,827 45,018.00
0.41 600763 C1 TOPCHOICE MEDI-A BYYFJH8 18.67 2,380 44,443.17
0.40 9926 HK AKESO INC BLFJ7Y1 1.67 25,700 43,020.77
0.39 000999 C2 CHINA RESOURCE-A BD5CL42 6.18 6,900 42,626.51
0.39 002007 C2 HUALAN BIOLOGI-A BD5CL19 2.86 14,870 42,482.89
0.38 IMAB I-MAB-SPONSORED ADR BKRRKY7 11.31 3,659 41,383.29
0.37 000423 C2 DONG-E-E-JIAOCO LTD-A BD5CM61 4.58 8,700 39,866.46
0.36 300529 C2 JAFRON BIOMEDI-A BFY8H03 6.39 6,100 38,972.89
0.36 300003 C2 LEPU MEDICAL TECHNOLOGY-A BD5CM16 2.64 14,701 38,764.28
0.36 002044 C2 MEINIAN ONEHEA-A BD73L10 0.74 52,220 38,724.62
0.33 603882 C1 GUANGZHOU KING-A BFYX689 11.61 3,100 35,994.06
0.32 300595 C2 OVCTEK CHINA INC-A BHQPSJ2 5.86 5,924 34,689.28
0.29 603456 C1 ZHEJIANG JIUZH-A BMQBVL8 6.78 4,600 31,190.13
0.27 600161 C1 BEIJING TIAN-A BP3R9J4 3.15 9,300 29,276.09
0.26 603707 C1 NANJING KING-F-A BF2DZL7 4.03 7,036 28,322.98
0.26 2500 HK VENUS MEDTECH -H BL6V047 1.44 19,700 28,309.03
0.26 002252 C2 SHANGHAI RAAS -A BD5CPJ5 0.84 33,300 27,940.82
0.26 600521 C1 ZHEJIANG HUAHA-A BP3RBR6 2.87 9,710 27,898.80
0.23 600079 C1 HUMANWELL HEAL-A BP3R712 2.42 10,100 24,409.07
0.22 000739 C2 APELOA PHARMA-A BD5LY17 3.23 7,500 24,252.34
0.22 300676 C2 BGI GENOMICS CO LTD-A BFY8H58 9.79 2,433 23,825.21
0.21 603127 C1 JOINN LABORATO-A BK94819 15.06 1,500 22,583.81
0.21 002030 C2 DAAN GENE CO LTD-A BD5CKW3 2.63 8,460 22,257.73
0.21 002223 C2 JIANGSU YUYUE-A BD5CJM6 3.36 6,600 22,180.53
0.20 000513 C2 LIVZON PHARM-A BD5CQ25 4.99 4,300 21,457.28
0.19 600380 C1 JOINCARE PHARM-A BP3RBV0 1.73 11,900 20,532.24
0.19 600511 C1 CHINA NATIONAL-A BP3R9B6 4.10 4,900 20,086.57
0.18 300357 C2 ZHEJIANG WOLWO-A BFY8GY0 6.06 3,223 19,530.01
0.18 CASH 1.00 19,241 19,227.35
0.18 300253 C2 WINNING HEALTH-A BD5CKZ6 1.24 15,270 18,970.63
0.17 300832 C2 SHENZHEN NEW-A BMXTX20 5.98 3,100 18,546.56
0.16 603658 C1 AUTOBIO DIAGNO-A BYW5N89 6.34 2,782 17,642.68
0.15 300558 C2 BETTA PHARMACE-A BD6QWL7 6.64 2,420 16,065.53
0.13 688185 C1 CANSINO BIOLOGICS INC-A BMD9JD3 22.27 605 13,471.95
0.11 300725 C2 PHARMABLOCK SC-A BFY8HC5 11.87 1,000 11,869.50
0.11 300677 C2 INTCO MEDICAL-A BMTCVT6 4.04 2,850 11,514.60
0.11 688202 C1 SHANGHAI MEDICILON INC-A BNR4NV7 51.26 221 11,329.05
Holdings are subject to change.

ETF Characteristics As of 05/26/22

Return on Equity 9.20%
Weighted Avg. Market Cap 15,280 M
2021 2022
Price-to-earnings 33.42 30.13
Price-to-book value 2.87 2.70

Source: AltaVista Research, LLC

ETF Risk Stats As of 05/26/22

Versus Beta
S&P 500 0.49
MSCI EAFE 0.51
MSCI Emg. Mkts 0.81
Standard Deviation 27.40%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.

Back to Top